Evidence map›Paper›PMID 30255005›Full record

ArticleFrontiers in pediatrics2018

A C126R

Jose Antonio Tavares de Albuquerque, Edgar Borges de Oliveira Junior, Nuria Bengala Zurro, Paola Vendramini, Edson Kiyotaka Ishizuka, Daniela de Souza Paiva Borgli, Monica Soares de Souza, Antonio Condino-Neto

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Novel Mutation in theFrontiers in pediatrics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jose Antonio Tavares de AlbuquerqueImmunogenic Assessoria e Diagnóstico em Saúde LTDA, São Paulo, Brazil.
Edgar Borges de Oliveira JuniorImmunogenic Assessoria e Diagnóstico em Saúde LTDA, São Paulo, Brazil.
Nuria Bengala ZurroDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Paola VendraminiDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Edson Kiyotaka IshizukaImmunogenic Assessoria e Diagnóstico em Saúde LTDA, São Paulo, Brazil.
Daniela de Souza Paiva BorgliHospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
Monica Soares de SouzaHospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
Antonio Condino-NetoDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRHospital Federal dos Servidores do Estado · BRHospital São Paulo · BRCentro de Estudos em Psicologia da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) is an innate immune deficiency of phagocytic cells caused by mutations that affect components of the NADPH oxidase system, with resulting impairment in reactive oxygen species production. Patients with CGD are susceptible to recurrent infections and hyperinflammatory responses. Mutations in

Indexed as

chronic granulomatous disease (CGD)CYBB geneNADPH oxidasenovel mutationpneumonia

Identifiers

PMID30255005
PMCPMC6141742
OpenAlexW2891227587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.